Article in Micromachines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Nhi N TrinhDepartment of Biomedical Engineering, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.
Leslie A SimmsDepartment of Mechanical and Aerospace Engineering, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.
Bradley S ChewDepartment of Mechanical and Aerospace Engineering, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.
Alexander WeinsteinDepartment of Mechanical and Aerospace Engineering, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.
Valeria La SaponaraDepartment of Mechanical and Aerospace Engineering, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0002-7963-262X
Mitchell M McCartneyDepartment of Mechanical and Aerospace Engineering, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0001-7236-8400
Nicholas J KenyonUC Davis Lung Center, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0001-8839-4400
Cristina E DavisDepartment of Mechanical and Aerospace Engineering, One Shields Avenue, University of California Davis, Davis, CA 95616, USA.
Funding
UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
UC Davis Environmental Health Sciences Core CenterP30ES023513 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Irva Hertz-Picciotto · 2015 to 2026
$26.0M
UC Davis Clinical and Translational Science CenterUL1TR000002 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$12.2M
TRAINING IN COMPARATIVE LUNG BIOLOGY AND MEDICINET32HL007013 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI Elena Goncharova, Nicholas J. KENYON · 1985 to 2026
$10.1M
Revisiting ReCHARGE: ECHO Follow up on Middle Childhood and AdolescenceUG3OD023365 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BENNETT, DEBORAH HALL, HERTZ-PICCIOTTO, IRVA · 2016 to 2024
$6.4M
Monitoring of disease-induced skin VOC patterns from handheld and wearable chemical sensorsU01TR004083 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CRISTINA ELIZABETH DAVIS, Nicholas J. KENYON · 2022 to 2026
$5.9M
Portable GC detector for breath-based COVID diagnosticsU18TR003795 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAVIS, CRISTINA ELIZABETH, KENYON, NICHOLAS J. · 2021 to 2022
$1.9M
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed VeteransI01BX004965 · VA · VA NORTHERN CALIFORNIA HEALTH CARE SYS · PI HARPER, RICHART W, KENYON, NICHOLAS J. · 2021 to 2025
–
Advanced Regenerative Manufacturing Institute, Inc. W911NF-17-3-0003BLRD VA I01 BX004965National Science Foundation 2200221NCATS NIH HHS U01 TR004083NCATS NIH HHS U18 TR003795NCATS NIH HHS UL1 TR000002NCATS NIH HHS UL1 TR001860NIEHS NIH HHS P30 ES023513NIH HHS 1P30ES023513-01A1NIH HHS 1U01TR004083NIH HHS 4U18TR003795NIH HHS NCATS 1U18TR003795,NIH HHS T32 HL07013NIH HHS UG3 OD023365NIH HHS UG3-OD023365NIH HHS UL1 TR001860United States Department of Veterans Affairs I01 BX004965-01A1University of California Tobacco-Related Disease Research Program T31IR1614
6 · The paper itself
Abstract
A bonding process was developed for glass-to-glass fusion bonding using Borofloat 33 wafers, resulting in high bonding yield and high flexural strength. The Borofloat 33 wafers went through a two-step process with a pre-bond and high-temperature bond in a furnace. The pre-bond process included surface activation bonding using O
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Glass-to-Glass Fusion Bonding Quality and Strength Evaluation with Time, Applied Force, and Heat. · full record | OpenQuestion